35th week of 2018 patent applcation highlights part 23 |
Patent application number | Title | Published |
20180244711 | CRYSTAL FORM OF FLUDARABINE PHOSPHATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 2018-08-30 |
20180244712 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | 2018-08-30 |
20180244713 | SIALYLTRANSFERASE INHIBITORS AND USES THEREOF | 2018-08-30 |
20180244714 | PROTOESCIGENIN DERIVATIVE, PROCESS OF ITS PREPARATION, USE OF SAID COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THAT COMPOUND | 2018-08-30 |
20180244715 | PROTEIN PURIFICATION | 2018-08-30 |
20180244716 | EGG WHITE PROCESSING | 2018-08-30 |
20180244717 | CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF | 2018-08-30 |
20180244718 | FOLDAMER HELIX BUNDLE-BASED MOLECULAR ENCAPSULATION | 2018-08-30 |
20180244719 | GAMMA-AA-PEPTIDE STAT3/DNA INHIBITORS AND METHODS OF USE | 2018-08-30 |
20180244720 | TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR | 2018-08-30 |
20180244721 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | 2018-08-30 |
20180244722 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) | 2018-08-30 |
20180244723 | HEME PEPTIDE MATERIALS FOR ANTI-INFLAMMATORY REGENERATIVE NANOBIOMEDICINE | 2018-08-30 |
20180244724 | POLYPEPTIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2018-08-30 |
20180244725 | PEPTIDE-BASED SYNTHETIC MOLECULES AND SILICA NANOSTRUCTURES | 2018-08-30 |
20180244726 | Fusion Protein | 2018-08-30 |
20180244727 | CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE | 2018-08-30 |
20180244728 | MINICIRCLE DNA VECTOR VACCINE PLATFORM FOR FOOT-AND-MOUTH DISEASE AND METHODS THEREOF | 2018-08-30 |
20180244729 | MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES | 2018-08-30 |
20180244730 | Methods and Products for Fusion Protein Synthesis | 2018-08-30 |
20180244731 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN | 2018-08-30 |
20180244732 | HERBICIDE-RESISTANT PROTEIN, ENCODING GENE AND USE THEREOF | 2018-08-30 |
20180244733 | ISOLATED POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME FOR GENERATING PLANTS WITH INCREASED CUTICLAR WATER PERMEABILITY | 2018-08-30 |
20180244734 | NOVEL PROTEINS AND DETECTION METHODS | 2018-08-30 |
20180244735 | Compositions and Methods of Use for Recombinant Human Secretoglobins | 2018-08-30 |
20180244736 | EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME | 2018-08-30 |
20180244737 | OPSIN POLYPEPTIDES AND METHODS OF USE THEREOF | 2018-08-30 |
20180244738 | TUMOR SUPPRESSOR SALL1 AS A THERAPEUTIC AGENT FOR TREATING CANCER | 2018-08-30 |
20180244739 | PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2018-08-30 |
20180244740 | BH3 PEPTIDES AND METHODS OF USE THEREOF | 2018-08-30 |
20180244741 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS | 2018-08-30 |
20180244742 | Double-Acylated GLP-1 Derivatives | 2018-08-30 |
20180244743 | Novel Insulin Derivatives and the Medical Uses Hereof | 2018-08-30 |
20180244744 | A PROCESS FOR OBTAINING INSULIN WITH CORRECTLY FORMED DISULFIDE BONDS | 2018-08-30 |
20180244745 | EPHA3 AND MULTI-VALENT TARGETING OF TUMORS | 2018-08-30 |
20180244746 | T CELL RECEPTORS (TCR) AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DIABETES | 2018-08-30 |
20180244747 | COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS | 2018-08-30 |
20180244748 | Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof | 2018-08-30 |
20180244749 | IMMUNOMODULATORY PROTEINS WITH TUNABLE AFFINITIES | 2018-08-30 |
20180244750 | METHODS FOR TREATMENT OF CANCER | 2018-08-30 |
20180244751 | SINGLE-CHAIN CD27-RECEPTOR AGONIST PROTEINS | 2018-08-30 |
20180244752 | SINGLE-CHAIN GITR-RECEPTOR AGONIST PROTEINS | 2018-08-30 |
20180244753 | SINGLE-CHAIN TL1A RECEPTOR AGONIST PROTEINS | 2018-08-30 |
20180244754 | NOVEL HUMAN SERUM ALBUMIN MUTANT | 2018-08-30 |
20180244755 | TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR | 2018-08-30 |
20180244756 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE | 2018-08-30 |
20180244757 | MONOCLONAL ANTIBODIES SPECIFIC FOR HEARTLAND VIRUS AND METHODS OF THEIR USE | 2018-08-30 |
20180244758 | MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS | 2018-08-30 |
20180244759 | NOVEL METHODS OF GENERATING ANTIBODIES | 2018-08-30 |
20180244760 | TETRA-SPECIFIC, OCTAMERIC BINDING AGENTS AND ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXIN A AND TOXIN B FOR TREATMENT OF C. DIFFICILE INFECTION | 2018-08-30 |
20180244761 | NOVEL ANTIBODY AGAINST RIBOSOMAL PROTEIN S3 AND COMPOSITION FOR DIAGNOSING BIOLOGICAL STRESS | 2018-08-30 |
20180244762 | DUAL PDGF/VEGF ANTAGONISTS | 2018-08-30 |
20180244763 | ANTI-TGF-BETA ANTIBODIES AND THEIR USE | 2018-08-30 |
20180244764 | ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME | 2018-08-30 |
20180244765 | BINDING MOLECULES | 2018-08-30 |
20180244766 | ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018-08-30 |
20180244767 | ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018-08-30 |
20180244768 | HUMAN ANTI-THYROGLOBULIN T CELL RECEPTORS | 2018-08-30 |
20180244769 | P2X7 RECEPTOR ANTAGONISTS AND AGONISTS | 2018-08-30 |
20180244770 | ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF | 2018-08-30 |
20180244771 | IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST | 2018-08-30 |
20180244772 | FUSION PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS WITH ENHANCED COMPLEMENT BINDING | 2018-08-30 |
20180244773 | ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES | 2018-08-30 |
20180244774 | ANTI-PVRIG ANTIBODIES AND METHODS OF USE | 2018-08-30 |
20180244775 | Antibody To Be Cross-Linked To Human SEMA3A And Use Thereof | 2018-08-30 |
20180244776 | Antibody To Be Cross-Linked To Human SEMA3A And Use Thereof | 2018-08-30 |
20180244777 | Novel Treatment Methods Based on Multifunctional Molecules | 2018-08-30 |
20180244778 | Humanized Antibodies to Cluster of Differentiation 3 (CD3) | 2018-08-30 |
20180244779 | IMMUNOMODULATORY AGENTS | 2018-08-30 |
20180244780 | Antibodies Directed Against ICOS and Uses Thereof | 2018-08-30 |
20180244781 | PD-1/PD-L1 INHIBITORS FOR THE TREATMENT OF CANCER | 2018-08-30 |
20180244782 | THERAPEUTIC USE OF INTEGRIN-BINDING ANTIBODIES | 2018-08-30 |
20180244783 | COMBINATION THERAPY FOR TREATMENT OF DISEASE | 2018-08-30 |
20180244784 | VEGFR2 ANTIBODIES | 2018-08-30 |
20180244785 | ANTI-FGFR ANTIBODIES AND METHODS OF USE | 2018-08-30 |
20180244786 | ANTI IL-3R ALPHA AGENTS AND USES THEREOF | 2018-08-30 |
20180244787 | ANTI-HUMAN CXCR3 ANTIBODIES FOR TREATMENT OF VITILIGO | 2018-08-30 |
20180244788 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF | 2018-08-30 |
20180244789 | ANTI-PRLR ANTIBODY-DRUG CONJUGATES (ADC) AND USES THEREOF | 2018-08-30 |
20180244790 | METHODS OF TREATING SKIN DISORDERS USING ANTI-IL-31RA ANTIBODIES | 2018-08-30 |
20180244791 | ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY | 2018-08-30 |
20180244792 | ANTI-FIBROTIC EFFECT OF CD70 | 2018-08-30 |
20180244793 | Anti-GITR Antibodies and Methods of Use Thereof | 2018-08-30 |
20180244794 | ASSESSING AND TREATING LYMPHOMA | 2018-08-30 |
20180244795 | ANTIBODIES AND ASSAYS FOR DETECTION OF CD37 | 2018-08-30 |
20180244796 | FULLY HUMAN ANTI-MESOTHELIN ANTIBODIES AND IMMUNE EFFECTOR CELLS TARGETING MESOTHELIN | 2018-08-30 |
20180244797 | CHIMERIC CYTOKINE RECEPTOR | 2018-08-30 |
20180244798 | Combination Therapy with Coagulation Factors and Multispecific Antibodies | 2018-08-30 |
20180244799 | MONOCLONAL ANTIBODIES AGAINST ANTITHROMBIN BETA | 2018-08-30 |
20180244800 | ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII | 2018-08-30 |
20180244801 | METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9 | 2018-08-30 |
20180244802 | ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY | 2018-08-30 |
20180244803 | Vivo Method for Generating Diversity in a Protein Scaffold | 2018-08-30 |
20180244804 | NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN | 2018-08-30 |
20180244805 | CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2018-08-30 |
20180244806 | RUBBER COMPOSITION | 2018-08-30 |
20180244807 | CROSS-LINKED HYALURONIC ACID GRAFTED WITH DEXTRAN | 2018-08-30 |
20180244808 | METHOD FOR PRODUCING MODIFIED DIENE-BASED RUBBER, RUBBER COMPOSITION AND TIRE | 2018-08-30 |
20180244809 | Methods For Preparation Of Functionalized Polymers | 2018-08-30 |
20180244810 | Methods of Relieving a Condition of Over-Pressure in a Vessel, Pressure Relief Assemblies, and Related Separator Vessels | 2018-08-30 |